REVELATION BIOSCIENCES, INC. — Net Income by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4c010ffc-7b05-4230-a7cd-b1fe06f3e15f/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-8.9M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-076552 |
| FY 2024 | $-15.0M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-034584 |
| FY 2023 | $-120.3k | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-035322 |
| FY 2022 | $-10.8M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-011000 |
| FY 2021 | $-12.0M | 2021-01-01 – 2021-12-31 | evidence 0000950170-23-011000 |
| FY 2020 | $-1.6M | 2020-01-01 – 2020-12-31 | evidence 0001213900-21-032736 |
| FY 2019 | $-3.6k | 2019-01-01 – 2019-12-31 | evidence 0001213900-21-019097 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).